Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

(2011) Yevgeniy Balagula et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Hautreaktionen unter EGFR-Inhibitoren – Klinik und Management

(2010) A Wollenberg et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4

(2010) Robert C. Miller et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Comparative Evaluation of Antipruritic Protocols in Acute Burns. The Emerging Value of Gabapentin in the Treatment of Burns Pruritus

(2010) Ioannis Goutos et al.   Journal of Burn Care & Research

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

Side-Effects of Long-Term Administration of Erlotinib in Patients with Non-small Cell Lung Cancer

(2010) Annemarie Becker et al.   Journal of Thoracic Oncology

Isotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer

(2010) Paolo Bidoli et al.   Journal of Thoracic Oncology

Aprepitant for Erlotinib-Induced Pruritus

(2010) Bruno Vincenzi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4)

(2010) A. Jatoi et al.   ONCOLOGIST

Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists

(2010) Jessica C. Hassel et al.   ONKOLOGIE

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

(2010) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors

(2009) A. Osio et al.   BRITISH JOURNAL OF DERMATOLOGY

Toxicity of Targeted Therapy in Non–Small-Cell Lung Cancer Management

(2009) Serena Ricciardi et al.   Clinical Lung Cancer

Erlotinib-Induced Skin Rash in Patients with Non–Small-Cell Lung Cancer: Pathogenesis, Clinical Significance, and Management

(2009) Sotirios Tsimboukis et al.   Clinical Lung Cancer

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption

(2009) Alon Scope et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia

(2009) T Eames et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cetuximab-induced Acneiform Eruption and the Response to Isotretinoin

(2008) P Vezzoli et al.   ACTA DERMATO-VENEREOLOGICA

Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study

(2008) D. Rigopoulos et al.   BRITISH JOURNAL OF DERMATOLOGY

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer

(2008) Chandra P. Belani et al.   CANCER

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes

(2008) Aminah Jatoi et al.   CANCER

Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation

(2008) Patrizia Racca et al.   Clinical Colorectal Cancer

Increased Oral Mucositis after IMRT versus Non-IMRT when Combined with Cetuximab and Cisplatin or Docetaxel for Head and Neck Cancer: Preliminary Results of RTOG 0234

(2008) D. Khuntia et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antimicrobial activity of sodium hypochlorite and chlorhexidine by two different tests

(2007) Luciana M. Sassone et al.   Australian Endodontic Journal